Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are already enrolled in a specific related study called the WU-PE-CGS study (IRB#202106129)
- People who have been diagnosed with cholangiocarcinoma (a type of bile duct cancer), OR people who have been diagnosed with multiple myeloma (a type of blood cancer) and identify as African American, OR people who have been diagnosed with colorectal cancer, identify as African American, and were 65 years of age or older at the time of their diagnosis
- People who are at least 18 years old
- People who are able to understand and agree to a consent form that has been reviewed and approved by an ethics board
- People who have access to a personal computer, tablet, or mobile device
Who may not be able to join:
- People who are not already enrolled in the WU-PE-CGS study (IRB#202106129)
- People diagnosed with multiple myeloma who do not identify as African American
- People diagnosed with colorectal cancer who do not identify as African American, or who were younger than 65 at the time of their diagnosis
- People under 18 years of age
- People who are unable to understand or agree to the ethics board-approved consent form
- People who do not have access to a personal computer, tablet, or mobile device
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Erin Linnenbringer, Ph.D., MS, Washington University School of Medicine
Phone: 314-747-1966
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in self-efficacy about genomic test results
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.